Analyst stock forecast
Palvella Therapeutics Stock Forecast and Analyst Price Target
PVLA analyst target range, upside, consensus rating and coverage count.
Direct answer
Palvella Therapeutics's average price target is $230.53.
The target implies +44.5% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $205.00 to $270.00, with 15 analysts in the current consensus when available.
Forecast evidence checked August 7, 2026.
Verified data
- Current price
- $159.54
- Average price target
- $230.53
- High price target
- $270.00
- Low price target
- $205.00
- Target upside
- +44.5%
- Consensus rating
- Strong Buy
- Analysts
- 15
- Evidence date
- August 7, 2026
- Valid through
- August 14, 2026